Esther
Molina Perez
Complexo Hospitalario Universitario de Santiago
Santiago de Compostela, EspañaPublicaciones en colaboración con investigadores/as de Complexo Hospitalario Universitario de Santiago (12)
2024
-
Development and Validation of a Scoring System to Predict Response to Obeticholic Acid in Primary Biliary Cholangitis
Clinical Gastroenterology and Hepatology, Vol. 22, Núm. 10, pp. 2062-2074.e11
-
Longitudinal outcomes of obeticholic acid therapy in ursodiol-nonresponsive primary biliary cholangitis: Stratifying the impact of add-on fibrates in real-world practice
Alimentary Pharmacology and Therapeutics, Vol. 59, Núm. 12, pp. 1604-1615
2023
-
Budesonide as first-line treatment in patients with autoimmune hepatitis seems inferior to standard predniso(lo)ne administration
Hepatology, Vol. 77, Núm. 4, pp. 1095-1105
-
The impact of obesity on postoperative complications and short-term survival after liver transplantation
European Journal of Gastroenterology and Hepatology, Vol. 35, Núm. 7, pp. 782-789
2022
-
Non-pharmacologic direct cost of a simplified strategy with glecaprevir/pibrentasvir for 8 weeks in naïve non-cirrhotic patients with hepatitis C implemented in clinical practice. The Just SIMPLE Study
Gastroenterologia y Hepatologia, Vol. 45, Núm. 5, pp. 342-349
-
Sinusoidal obstruction syndrome after liver transplantation: A multicenter observational study
Liver Transplantation, Vol. 28, Núm. 7, pp. 1257-1261
2021
-
Retrieval and treatment of patients with primary biliary cholangitis who are lost in the health system
Revista espanola de enfermedades digestivas : organo oficial de la Sociedad Espanola de Patologia Digestiva, Vol. 113, Núm. 11, pp. 776-779
2020
-
Ribavirin as a first treatment approach for hepatitis e virus infection in transplant recipient patients
Microorganisms, Vol. 8, Núm. 1
2016
-
Randomized controlled trial of the NS5A inhibitor daclatasvir plus pegylated interferon and ribavirin for HCV genotype-4 (COMMAND-4)
Antiviral Therapy, Vol. 21, Núm. 3, pp. 195-205
2013
-
Cholangitis and multiple liver abscesses after percutaneous ethanol injection (PEI) for recurrent hepatocellular carcinoma (HCC)
Revista Espanola de Enfermedades Digestivas
2012
-
Basiliximab en el tratamiento del rechazo celular agudo resistente a los corticoides postrasplante hepático
Gastroenterologia y Hepatologia, Vol. 35, Núm. 9, pp. 649-651
-
Indicaciones actuales de tratamiento triple para la hepatitis C
Gastroenterologia y Hepatologia, Vol. 35, Núm. 4, pp. 266-277